Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Receptor-type tyrosine-protein kinase FLT3 | ||
Ligand | BDBM50055498 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_1451318 (CHEMBL3363337) | ||
IC50 | 1.2±n/a nM | ||
Citation | Zhang, W; DeRyckere, D; Hunter, D; Liu, J; Stashko, MA; Minson, KA; Cummings, CT; Lee, M; Glaros, TG; Newton, DL; Sather, S; Zhang, D; Kireev, D; Janzen, WP; Earp, HS; Graham, DK; Frye, SV; Wang, X UNC2025, a potent and orally bioavailable MER/FLT3 dual inhibitor. J Med Chem57:7031-41 (2014) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Receptor-type tyrosine-protein kinase FLT3 | |||
Name: | Receptor-type tyrosine-protein kinase FLT3 | ||
Synonyms: | CD135 | CD_antigen: CD135 | FL cytokine receptor | FLK-2 | FLK2 | FLT-3 | FLT3 | FLT3_HUMAN | Fetal liver kinase-2 | Fms-like tyrosine kinase 3 | Fms-like tyrosine kinase 3 (Flt-3) | Fms-related tyrosine kinase 3 | STK-1 | STK1 | Stem cell tyrosine kinase 1 | ||
Type: | Enzyme | ||
Mol. Mass.: | 112888.62 | ||
Organism: | Homo sapiens (Human) | ||
Description: | P36888 | ||
Residue: | 993 | ||
Sequence: |
| ||
BDBM50055498 | |||
n/a | |||
Name | BDBM50055498 | ||
Synonyms: | CHEMBL3326004 | US10004755, Compound UNC1669A | US9795606, B28 | ||
Type | Small organic molecule | ||
Emp. Form. | C27H37FN6O3S | ||
Mol. Mass. | 544.684 | ||
SMILES | CCCCNc1ncc2c(cn([C@H]3CC[C@H](O)CC3)c2n1)-c1ccc(c(F)c1)S(=O)(=O)N1CCN(C)CC1 |r,wU:12.11,wD:15.15,(-3.17,-12.13,;-1.85,-11.36,;-.52,-12.13,;.83,-11.36,;2.16,-12.13,;3.49,-11.36,;3.49,-9.82,;4.82,-9.05,;6.15,-9.81,;7.63,-9.33,;8.54,-10.59,;7.63,-11.84,;8.11,-13.31,;9.61,-13.63,;10.08,-15.1,;9.05,-16.24,;9.52,-17.7,;7.54,-15.91,;7.07,-14.45,;6.16,-11.36,;4.82,-12.13,;8.11,-7.87,;9.62,-7.55,;10.09,-6.1,;9.07,-4.95,;7.56,-5.27,;6.54,-4.12,;7.08,-6.73,;9.55,-3.48,;8.06,-3.08,;9.15,-1.99,;11.06,-3.18,;12.07,-4.34,;13.57,-4.04,;14.07,-2.59,;15.58,-2.29,;13.05,-1.43,;11.54,-1.73,)| | ||
Structure |